Fair Prices Call Prompts EU Industry To Insist On Innovation Incentives
Common Definition Of 'Unmet Medical Need' Required
Executive Summary
Participants at a workshop on the EU’s proposed Pharmaceutical Strategy discussed affordability and drug shortages and called for more urgency on the draft HTA regulation.
You may also be interested in...
EU Orphan Law Under Attack Over ‘Flawed Incentives’
The European Commission says it will publish its review of the EU orphan drug legislation in the coming days.
EU’s Joint Regulatory/HTA System Praised, But Improvements Needed
Panelists at the virtual DIA Europe 2020 conference heard some good news about progress with the EU’s parallel consultation system for scientific advice, and some not so good news about continuing differences in health technology assessments at national level across Europe.
EU Drug Regulatory Network Faces Up To An Uncertain And Complex Future
Regulators have produced yet another strategy outlining the challenges and next steps for the European drug regulatory network as the network prepares for a future characterized by rapid developments in science and technology, medicines access issues, supply chain weaknesses and emerging health threats.